Warning Letters for Companies selling CBD containing Food and Beverages
Recommendation

19/20 May 2026
All relevant GMP/GACP aspects for Medical Cannabis
The U.S. FDA warns five companies for illegally selling food and beverage products containing cannabidiol (CBD).
According to the FDA, the companies are selling CBD products that people may confuse for traditional foods or beverages which may result in unintentional consumption or overconsumption of CBD. "CBD-containing products in forms that are appealing to children, such as gummies, hard candies and cookies, are especially concerning", the agency says. The FDA previously issued several Warning Letters to companies illegally selling CBD containing products.
According to the agency, the use of CBD raises safety concerns, especially with long-term use. "The FDA has not found adequate information showing how much CBD can be consumed, and for how long, before causing harm. This is particularly true for vulnerable populations like children and those who are pregnant."
In addition, FDA experts commented on the agency’s concerns with adding CBD to food and on information they want consumers to know.
More information is available in FDA Warns Companies for Illegally Selling Food and Beverage Products that Contain CBD published on the agency´s website.
Related GMP News
23.04.2026EMA publishes Draft Guideline on the Declaration of Active Substances in Herbal Drugs
23.04.2026Plans to reclassify Hexahydrocannabinol
02.04.2026What are the GMP Requirements for Medical Cannabis?
02.04.2026EFSA sets Cannabidiol (CBD) Safety Limit
02.04.2026What are the GMP Requirements for Herbal Medicinal Products?
03.03.2026Can Steam Treatment be used to Decontaminate Cannabis?


